TickerFacts.

Curanex Pharmaceuticals Inc (CURX): Total Assets

Annual figures by period end, from SEC filings.

$11.58M
As of 2025-12-31
$5.07M
As of 2026-06-30
2024-12-31: $517.9K2025-12-31: $11.58M$11.58M
2024-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$11.58Mn/m2026-03-30, Balance as of period end
2024-12-31$517.9Kn/a2026-03-30, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Curanex Pharmaceuticals Inc (CURX)2025-12-31$11.58Mn/m
Revelation Biosciences, Inc. (REVB)2025-12-31$11.58M+74.9%
NewcelX Ltd. (NCEL)2025-12-31$11.45Mn/m
PRF Technologies Ltd. (PRFX)2025-12-31$12.00M+165.1%
MetaVia Inc. (MTVA)2025-12-31$11.12M-31.6%
Mira Pharmaceuticals, Inc. (MIRA)2025-12-31$11.09M+279.5%
Decoy Therapeutics Inc. (DCOY)2025-12-31$11.06M+265.8%
Anebulo Pharmaceuticals, Inc. (ANEB)2025-06-30$12.15M+198.2%
Lantern Pharma Inc. (LTRN)2025-12-31$11.04M-56.8%

Compare CURX, REVB, NCEL, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗